Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Targeting receptor for advanced glycation end products (RAGE) expression induces apoptosis and inhibits prostate tumor growth.

Elangovan I, Thirugnanam S, Chen A, Zheng G, Bosland MC, Kajdacsy-Balla A, Gnanasekar M.

Biochem Biophys Res Commun. 2012 Jan 27;417(4):1133-8. doi: 10.1016/j.bbrc.2011.12.060. Epub 2011 Dec 20.

PMID:
22206663
2.

RAGE and its ligands in bone metabolism.

Zhou Z, Xiong WC.

Front Biosci (Schol Ed). 2011 Jan 1;3:768-76. Review.

3.

Perspectives on RAGE signaling and its role in cardiovascular disease.

Cohen MM Jr.

Am J Med Genet A. 2013 Nov;161A(11):2750-5. doi: 10.1002/ajmg.a.36181. Epub 2013 Oct 3. Review.

PMID:
24123885
4.

HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation.

Nogueira-Machado JA, Volpe CM, Veloso CA, Chaves MM.

Expert Opin Ther Targets. 2011 Aug;15(8):1023-35. doi: 10.1517/14728222.2011.575360. Epub 2011 May 17. Review.

PMID:
21585289
5.

Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer.

Ohmori H, Luo Y, Kuniyasu H.

Expert Opin Ther Targets. 2011 Feb;15(2):183-93. doi: 10.1517/14728222.2011.546785. Epub 2011 Jan 5. Review.

PMID:
21204727
6.

Role of receptor for advanced glycation end products in the complication and progression of various types of cancers.

Malik P, Chaudhry N, Mittal R, Mukherjee TK.

Biochim Biophys Acta. 2015 Sep;1850(9):1898-904. doi: 10.1016/j.bbagen.2015.05.020. Epub 2015 May 29. Review.

PMID:
26028296
7.

Delivering RNAi therapeutics with non-viral technology: a promising strategy for prostate cancer?

Guo J, Evans JC, O'Driscoll CM.

Trends Mol Med. 2013 Apr;19(4):250-61. doi: 10.1016/j.molmed.2013.02.002. Epub 2013 Mar 14. Review.

PMID:
23499575
8.

S100P: a novel therapeutic target for cancer.

Arumugam T, Logsdon CD.

Amino Acids. 2011 Oct;41(4):893-9. doi: 10.1007/s00726-010-0496-4. Epub 2010 May 28. Review.

9.

Is EGR1 a potential target for prostate cancer therapy?

Gitenay D, Baron VT.

Future Oncol. 2009 Sep;5(7):993-1003. doi: 10.2217/fon.09.67. Review.

Items per page

Supplemental Content

Write to the Help Desk